Meeting
2023 ASCO Gastrointestinal Cancers Symposium
A multicenter study to investigate the role of sarcopenia as a prognostic factor in patients with hepatocellular carcinoma treated by trans-arterial radioembolization.
Authors
Heechul Nam
The Catholic University of Korea, Seoul, South Korea;
Heechul Nam , Hyun Yang , Yeon Seok Seo , Do Young Kim , Yoon Jun Kim , Si Hyun Bae
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 532)
DOI
10.1200/JCO.2023.41.4_suppl.532
Abstract #
532
Poster Bd #
C2
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Real-world experience and outcomes of hepatocellular carcinoma (HCC) treated with transarterial radioembolization (TARE).
First Author: Parthib Das
Poster
2023 ASCO Breakthrough
Serum-based parameters as distinctive predictive biomarkers in patients with hepatocellular carcinoma undergoing curative radiation therapy.
First Author: Dong-Soo Lee
Poster
2021 ASCO Annual Meeting
Prognostic and predictive factors in patients treated with ramucirumab (RAM) with advanced hepatocellular carcinoma (aHCC) and elevated alpha-fetoprotein (AFP): Results from two phase III trials.
First Author: Josep M. Llovet
Poster
2020 ASCO Virtual Scientific Program
Prognostic significance of nutritional markers in metastatic gastric and esophageal adenocarcinoma.
First Author: Lucy Xiaolu Ma